“METASTATIC CHOLANGIOCARCINOMA AS A TARGET OF MOLECULAR-DIRECTED THERAPY”. Voprosy Onkologii, vol. 64, no. 5, May 2018, pp. 671-7, https://doi.org/10.37469/0507-3758-2018-64-5-671-677.